Clinical trial
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
NCT00194740 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00194740 |
|---|---|
| Title | Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer |
| Official title | Taxotere Plus Weekly Navelbine and G-CSF: A Phase II Study in Stage IV Breast Cancer |
| Lead sponsor | University of Washington, Other |
| Collaborators | Aventis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasm |
| Intervention type | Drug |
| Interventions | Docetaxel, Vinorelbine, Filgrastim |
| Enrollment | 48 |
| Start date | Nov 1, 1997 |
| Completion | Jun 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: